| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026041442 |
| P356 | DOI | 10.1007/S13277-016-4871-Y |
| P698 | PubMed publication ID | 26873490 |
| P2093 | author name string | Yang Chen | |
| Shiren Sun | |||
| Xiaoxuan Ning | |||
| Xiaosu Wang | |||
| Qiaoneng Li | |||
| P2860 | cites work | Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro | Q24294467 |
| CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family | Q24298639 | ||
| Structural analysis of Siah1-Siah-interacting protein interactions and insights into the assembly of an E3 ligase multiprotein complex | Q24313326 | ||
| p30, a novel protein target of mouse calcyclin (S100A6) | Q24529997 | ||
| Development of anticancer agents targeting the Wnt/β-catenin signaling | Q26781898 | ||
| Curcumin and tumor immune-editing: resurrecting the immune system | Q26783491 | ||
| Structure of the S100A6 Complex with a Fragment from the C-Terminal Domain of Siah-1 Interacting Protein: A Novel Mode for S100 Protein Target Recognition † ‡ | Q27652244 | ||
| Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses | Q28199204 | ||
| Ca2+-dependent translocation of the calcyclin-binding protein in neurons and neuroblastoma NB-2a cells | Q28505063 | ||
| Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin | Q28511663 | ||
| Elk-1 associates with the mitochondrial permeability transition pore complex in neurons | Q28568322 | ||
| Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes | Q28571544 | ||
| The modular structure of SIP facilitates its role in stabilizing multiprotein assemblies | Q28910203 | ||
| Biomarker discovery: a proteomic approach for brain cancer profiling | Q30159478 | ||
| Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress. | Q30370976 | ||
| Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS | Q33326878 | ||
| Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines | Q33997546 | ||
| CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation | Q34008646 | ||
| Identification of Siah-interacting protein as a potential regulator of apoptosis and curcumin resistance. | Q34132648 | ||
| S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis | Q34147535 | ||
| Translocation and phosphorylation of calcyclin binding protein during retinoic acid-induced neuronal differentiation of neuroblastoma SH-SY5Y cells | Q34219333 | ||
| Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma | Q34614359 | ||
| Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling | Q34815988 | ||
| Role of the CacyBP/SIP protein in gastric cancer | Q35742059 | ||
| Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway | Q35785146 | ||
| Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin | Q36329814 | ||
| S100A6 and CacyBP/SIP - two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. | Q36337330 | ||
| Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey | Q36744057 | ||
| iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis | Q37001972 | ||
| S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function | Q37698305 | ||
| Up-regulation of CacyBP/SIP during rat breast cancer development | Q37717902 | ||
| β-catenin in oral cancer: an update on current knowledge | Q38226652 | ||
| Integrative signaling by minimal erythropoietin receptor forms and c-Kit | Q38305477 | ||
| Characterization of the interaction of calcyclin (S100A6) and calcyclin-binding protein. | Q38310724 | ||
| Influence of S100A6 on CacyBP/SIP Phosphorylation and Elk-1 Transcriptional Activity in Neuroblastoma NB2a Cells | Q38862784 | ||
| CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2. | Q39184959 | ||
| Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons | Q39679229 | ||
| CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. | Q39891409 | ||
| Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer | Q40028825 | ||
| Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs. | Q40489852 | ||
| Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). | Q40510837 | ||
| Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. | Q40840516 | ||
| Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer | Q44041562 | ||
| Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint | Q46042325 | ||
| Relationship between CacyBP/SIP expression and prognosis in astrocytoma | Q49039254 | ||
| CacyBP/SIP protein is important for the proliferation of human glioma cells. | Q53057230 | ||
| Expression and clinical significance of CacyBP/SIP in pancreatic cancer. | Q53317977 | ||
| Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. | Q53360582 | ||
| The expression of β-catenin in different subtypes of breast cancer and its clinical significance. | Q54354737 | ||
| Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells | Q57363958 | ||
| CacyBP/SIP interacts with tubulin in neuroblastoma NB2a cells and induces formation of globular tubulin assemblies | Q62590194 | ||
| Interactions of microtubule-associated protein MAP2 with unpolymerized and polymerized tubulin and actin using a 96-well microtiter plate solid-phase immunoassay | Q72076915 | ||
| Calcyclin (S100A6) binding protein (CacyBP) is highly expressed in brain neurons | Q74197987 | ||
| CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells | Q83300307 | ||
| CacyBP/SIP expression is involved in the clinical progression of breast cancer | Q84495962 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 10785-10791 | |
| P577 | publication date | 2016-02-13 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | The potential role of CacyBP/SIP in tumorigenesis | |
| P478 | volume | 37 |
| Q94475249 | Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma |
| Q59138386 | Cysteine Proteases from () Inhibit Melanoma Metastasis and Modulate Expression of Proteins Related to Proliferation, Migration and Differentiation |
| Q33705505 | MAP kinase p38 is a novel target of CacyBP/SIP phosphatase |
| Q38442994 | Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis. |
| Q47339218 | Transcriptional regulation of CacyBP/SIP gene and the influence of increased CacyBP/SIP level on gene expression pattern in colorectal cancer HCT116 cells |
Search more.